GAMMA Investing
RCKT icon

GAMMA Investing’s Rocket Pharmaceuticals RCKT Stock Holding History

GAMMA Investing’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.57K Buy
1,359
+146
+12% +$506 ﹤0.01% 3777
2026
Q2 		$4.15K Sell
1,213
-1,066
-47% -$3.54K ﹤0.01% 3551
2026
Q1 		$8.16K Buy
2,279
+2,188
+2,404% +$8.7K ﹤0.01% 3178
2025
Q4 		$319 Buy
+91
New +$312 ﹤0.01% 3955
2025
Q3 		– Sell
-830
Closed -$2.03K – 3912
2025
Q2 		$2.03K Buy
830
+398
+92% +$2.02K ﹤0.01% 3398
2025
Q1 		$2.88K Buy
432
+170
+65% +$1.68K ﹤0.01% 3293
2024
Q4 		$3.29K Buy
262
+190
+264% +$2.86K ﹤0.01% 3063
2024
Q3 		$1.33K Buy
72
+20
+38% +$410 ﹤0.01% 3182
2024
Q2 		$1.12K Buy
52
+14
+37% +$322 ﹤0.01% 3027
2024
Q1 		$1.02K Buy
38
+15
+65% +$426 ﹤0.01% 2935
2023
Q4 		$661 Buy
+23
New +$508 ﹤0.01% 2900

Other funds holding RCKT

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Sanders Morris Harris
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

GAMMA Investing's RCKT Position: Q3 2026 in Review

GAMMA Investing increased its Rocket Pharmaceuticals (RCKT) stake by 12% in Q3 2026, buying an estimated $506 and bringing the position to 1,359 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3777.

GAMMA Investing first reported a position in RCKT in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.16K in Q1 2026. 15 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • GAMMA Investing held 1,359 shares of Rocket Pharmaceuticals worth $3.57K as of Q3 2026.
  • GAMMA Investing bought 146 Rocket Pharmaceuticals shares in Q3 2026, an estimated $506.
  • Rocket Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3777 holding.
  • GAMMA Investing first reported a position in Rocket Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Rocket Pharmaceuticals position peaked at $8.16K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.